<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="the hepatitis A virus and hepatitis B virus compared with" exact="the United States" post="and Western Europe. Thus, members of IBD research group"/>
 <result pre="hepatitis A virus and hepatitis B virus compared with the" exact="United States" post="and Western Europe. Thus, members of IBD research group"/>
 <result pre="for the HAV, while HBV shows moderate prevalence compared with" exact="United States" post="and Western Europe. Thus, members of the IBD research"/>
 <result pre="immunization of children. In areas of low endemicity (such as" exact="the United States" post="and Western Europe), infection is less frequent, but the"/>
 <result pre="of children. In areas of low endemicity (such as the" exact="United States" post="and Western Europe), infection is less frequent, but the"/>
 <result pre="and Prevention and the Advisory Committee on Immunization Practices of" exact="the United States" post="Centers for Disease Control and Prevention, recommend protection (ideally"/>
 <result pre="Prevention and the Advisory Committee on Immunization Practices of the" exact="United States" post="Centers for Disease Control and Prevention, recommend protection (ideally"/>
 <result pre="Western Europe, etc.), 2%–7% in those with moderate prevalence (e.g.," exact="South Korea," post="Mediterranean countries, Japan, Central Asia, Middle East, and parts"/>
 <result pre="South America), and more than 8% in West Africa and" exact="South Sudan," post="which have the highest prevalence rates [37,38]. In Korea,"/>
 <result pre="is not high [53,57], according to a study conducted in" exact="Spain" post="involving more than 2,000 patients with IBD, only 12%"/>
 <result pre="Infect Dis2007741041917521594 55MereckieneJCotterSLopalcoPet al.Hepatitis B immunisation programmes in European Union," exact="Norway" post="and Iceland: where we were in 2009?Vaccine2010284470447720451643 56collab: WHO"/>
 <result pre="traditional and biologic disease- modifying antirheumatic drugs: part II safety" exact="Canada" post="The Journal of Rheumatology 2012 39/1583-1602 van Assen et"/>
 <result pre="Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseases" exact="Swiss" post="Swiss Medical Weekly 2015 145/W14159 Cordeiro et al. [16]"/>
 <result pre="recommendations for adult patients with autoimmune inflammatory rheumatic diseases Swiss" exact="Swiss" post="Medical Weekly 2015 145/W14159 Cordeiro et al. [16] Recommendations"/>
 <result pre="systemic inflammatory rheumatic diseases from the Portuguese Society of Rheumatology" exact="Portugal" post="Acta Reumatológica Portuguesa 2016 41/112-130 ACG, American College of"/>
</results>
